Advanced Prostate Cancer Video Perspectives

William K. Oh, MD

Oh reports serving as a consultant for Archetype Therapeutics, AstraZeneca and Pfizer.
February 03, 2025
1 min watch
Save

VIDEO: PSMA PET imaging 'single most important advance' in advanced prostate cancer

Transcript

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

I think we're in a very significant new era with regard to managing advanced prostate cancer. I think one of the most significant recent advances is the use of PSMA imaging, PET scan in particular. It's given us an ability to see cancer, but not only that, really target it with radioligands, and I think there are gonna be other PSMA-targeted treatments coming down the pike, including immunotherapy and bispecifics.

That probably is the most single, most important advance over the past few years. We're also, I think, more routinely incorporating genomic testing, understanding the value of PARP inhibitors, for instance, and really also shifting the use of all of these treatments earlier into the patient's disease course. That has really, truly, I think, allowed men to live longer and potentially better lives.